Centro de Atendimento a Pacientes Especiais da FOUSP

Dr. Centro de Atendimento a Pacientes Especiais da FOUSP


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Oral Oncology
Verified
Journal Article
Closed access
FMFabiana Martins
Fabiana Martins
MOMárcio Augusto de Oliveira
Márcio Augusto de Oliveira
QWQian Wang
Qian Wang
SSStephen Sonis
Stephen Sonis
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP
NTNathaniel Treister
Nathaniel Treister

1 January 2005 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
CFCristiane Furuse
Cristiane Furuse
SSSuzana O. Machado de Sousa
Suzana O. Machado de Sousa
FNFabio Daumas Nunes
Fabio Daumas Nunes
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP
VAVera Cavalcanti de Arauijo
Vera Cavalcanti de Arauijo
We compared the immunoexpression of 5 myoepithelial cell (MEC) markers (asmooth-muscle actin, calponin, h-caldesmon, vimentin, and S-100-protein) using 16 pleomorphic adenomas (PA), 15 adenoid cystic carcinomas (ACC), and 3 epithelialmyoepithelial carcinomas (EMC) of salivary glands. The cx-smooth-muscle actin was useful for identification of MECs, especially in cribriform and tubular ACC, followed by EMC. Calponin was similar to ct-smooth-muscle actin, except for polygonal and plasmacytoid cells of PA and for solid ACC, which showed a-smooth-muscle actin negative and calponin positive. H-caldesmon was negative. Vimentin immunostained all MEC types, and was negative in luminal cells. S-100 protein was expressed both in the nuclei and cytoplasm of MECs and luminal cells, especially in PA. The best way to identify MEC is using a-smooth-muscle actin or calponin, plus vimentin, since in tumors MECs are hardly ever fully differentiated.

10 November 2011 in Special Care in Dentistry
Verified
Journal Article
Closed access
PDF file
JAJenny Abanto
Jenny Abanto
ACAna Lidia Ciamponi
Ana Lidia Ciamponi
EFElizabeth Francischini
Elizabeth Francischini
CMChristiana Murakami
Christiana Murakami
NRNathalie Pepe Medeiros de Rezende
Nathalie Pepe Medeiros de Rezende
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP

11 August 2009 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
RCRenata Rodrigues de Carvalho
Renata Rodrigues de Carvalho
FEFernanda de Paula Eduardo
Fernanda de Paula Eduardo
KRKaren Müller Ramalho
Karen Müller Ramalho
JAJosé Leopoldo Ferreira Antunes
José Leopoldo Ferreira Antunes
LBLetícia Mello Bezinelli
Letícia Mello Bezinelli
CECarlos de Paula Eduardo
Carlos de Paula Eduardo

15 March 2016 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
FMFabiana Martins
Fabiana Martins
SSSuzana Com de Sousa
Suzana Com de Sousa
ESElisa dos Santos
Elisa dos Santos
SWSook‐Bin Woo
Sook‐Bin Woo
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP

1 January 2005 in Journal of Oral Science
Verified
Journal Article
Open access
PDF file
ETEveline Turatti
Eveline Turatti
ANAdriana da Costa Neves
Adriana da Costa Neves
CFCentro de Atendimento a Pacientes Especiais da FOUSP
Centro de Atendimento a Pacientes Especiais da FOUSP
SSSuzana Orsini Machado de Sousa
Suzana Orsini Machado de Sousa
Some oral cancers are known to develop from dysplastic oral epithelium. In the present study, the expression of c-Jun, c-Fos, and cyclin D1 proteins in oral epithelial lesions with different degrees of dysplasia, and in oral squamous cell carcinomas (OSCCs) was evaluated. Eighteen cases of mild dysplasia, 23 cases of moderate to severe dysplasia and 24 OSCCs were studied immunohistochemically. Additionally, 15 sections of oral mucosa without any evidence of dysplasia were included in the study. Results: c-Jun expression increased according to the degree of oral dysplasia, with the greatest expression found in OSCC. c-Fos expression was intense in normal mucosa, reduced in mild dysplasia and high in moderate to severe dysplasia and in OSCCs. Cyclin D1 was expressed in only a few cases of moderate to severe dysplasia and in most of the OSCCs. Statistical analysis showed a correlation between the three proteins and the degree of epithelial alteration. The present results indicate a possible role of c-Jun and c-Fos in malignant transformation of oral mucosa. (J. Oral Sci. 47, 71-76, 2005)